High-affinity block of voltage-operated rat IIA neuronal sodium channels by 2,6 di-tert-butylphenol, a propofol analogue

European Journal of Anaesthesiology

Volumn 20, Issue 3, 2003, Pages 220-224

  Haeseler, G ^a   Leuwer, M ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Anaesthetics, intravenous, propofol; Biochemical phenomena, binding sites; Membrane transport proteins, ion channels, sodium channels; Phenols, 2,6 di tert butylphenol

Indexed keywords

2,6 DI TERT BUTYLPHENOL; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; LOCAL ANESTHETIC AGENT; PROPOFOL; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; NONHUMAN; RAT; SODIUM CURRENT; STRUCTURE ACTIVITY RELATION;

ANESTHETICS, INTRAVENOUS; ANIMALS; ELECTROPHYSIOLOGY; ION CHANNEL GATING; NEURONS; PATCH-CLAMP TECHNIQUES; PHENOLS; PROPOFOL; RATS; RECEPTORS, GABA-A; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS;

EID: 0037338035     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021503000371     Document Type: Article

References (19)

1. Rehberg B, Bennett E, Xiao YH, Levinson SR, Duch DS. Voltage- and frequency-dependent pentobarbital suppression of brain and muscle sodium channels expressed in a mammalian cell line. Mol Pharmacol 1995; 48: 89-97.
2. Rehberg B, Xiao YH, Duch DS. Central nervous system sodium channels are significantly suppressed at clinical concentrations of volatile anesthetics. Anesthesiology 1996; 84: 1223-1233.
3. Rehberg B, Duch D. Suppression of central nervous system sodium channels by propofol. Anesthesiology 1999; 91: 512-520.
4. Haeseler G, Störmer M, Bufler J, et al. Propofol blocks skeletal muscle sodium channels in a voltage-dependent manner. Anesth Analg 2001; 92: 1192-1198.
5. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367: 607-614.
6. Haeseler G, Piepenbrink A, Bufler J, et al. Structural requirements for voltage-dependent block of muscle sodium channels by phenol derivatives. Br J Pharmacol 2001; 132: 1916-1924.
7. A receptor but not with lipid solubility. J Pharmacol Exp Therapeut 2001; 297: 338-351.
8. A-receptors. Eur J Pharmacol 2001; 421: 85-91.
9. Lingamaneni R, Krasowski MD, Jenkins A, et al. Anesthetic properties of 4-iodopropofol: implications for mechanisms of anesthesia. Anesthesiology 2001; 94: 1050-1057.
10. A receptors. J Med Chem 1998; 41: 1846-1854.
11. James R, Glen JB. Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents. J Med Chem 1980; 23: 1350-1357.
12. Sarkar SN, Adhikari A, Sikdar SK. Kinetic characterization of rat brain type IIA sodium channel alpha-subunit stably expressed in a somatic cell line. J Physiol 1995; 488: 633-645.
13. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 1981; 391: 85-100.
14. Wang DW, George AL, Bennett PB. Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels. Biophys J 1996; 70: 238-245.
15. + channels. Eur J Pharmacol 1998; 342: 93-104.
16. Wang GK, Quan C, Vladimirov M, Mok WM, Thalhammer JG. Quaternary ammonium derivative of lidocaine as a long-acting local anesthetic. Anesthesiology 1995; 83: 1293-1301.
17. Gerner P, Nakamura T, Quan CF, Anthony DC, Wang GK. Spinal tonicaine. Anesthesiology 2000; 92: 1350-1360.
18. +channels. J Gen Physiol 1990; 96: 1105-1127.
19. + channels. Mol Pharmacol 1993; 44: 667-676.